Because tau deficiency inhibits APP trafficking to the membrane, it cannot interact with Fpn and inhibits iron efflux from neurons, which results in intracellular iron accumulation and dopaminergic neuronal death, dementia, and AD. This evidence concerns the gene MAPT and Alzheimer disease.